Filings for Rule Number 4123-6-21.2

Title Pharmacy and therapeutics committee.
Agency Bureau of Workers' Compensation
Division
Contact Eva Dixon
Phone 614-644-8346

Actions

Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
No Current Actions
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Documents
Pharmacy and therapeutics committee. 07/18/2024 Final File Amendment 119.03 08/01/2024 N
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 05/13/2024 Original File Amendment 119.03 06/13/2024 N
Public Notice
RSFA Analysis
Rule Body
Hearing Summary Report
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 01/18/2022 Final File Amendment 119.03 02/01/2022 Y
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 11/12/2021 Original File Amendment 119.03 12/20/2021 Y
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 05/23/2017 Final File Amendment 119.03 06/02/2017 N
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 03/16/2017 Original File Amendment 119.03 04/25/2017 N
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 09/19/2016 Final File Amendment 119.03 10/01/2016 N
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 07/13/2016 Original File Amendment 119.03 08/18/2016 N
Public Notice
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 08/26/2015 No Change No Change 119.03 Y
RSFA Analysis
Rule Body
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum of Response
Pharmacy and therapeutics committee. 01/10/2012 Final File Amendment 119.03 02/01/2012 N
Rule Body
Pharmacy and therapeutics committee. 11/01/2011 Original File Amendment 119.03 12/09/2011 N
Public Notice
RSFA Analysis
Rule Body
Pharmacy and Therapeutics Committee . 12/30/2010 Final File New 119.03 01/10/2011 N
Rule Body
Pharmacy and Therapeutics Committee . 10/25/2010 Original File New 119.03 11/30/2010 N
Public Notice
RSFA Analysis
Rule Body
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Public Notice
RSFA Analysis
Rule
Appendices
Hearing Summary Reports
CSI Business Impact Analysis
CSI Recommendation
CSI Agency Memorandum
    of Response
Title File Date Action Type Class Hearing Eff Date Exp Date FYR
Pharmacy and therapeutics committee. 07/18/2024 Final File Amendment 119.03 08/01/2024 N
Pharmacy and therapeutics committee. 05/13/2024 Original File Amendment 119.03 06/13/2024 N
Pharmacy and therapeutics committee. 01/18/2022 Final File Amendment 119.03 02/01/2022 Y
Pharmacy and therapeutics committee. 11/12/2021 Original File Amendment 119.03 12/20/2021 Y
Pharmacy and therapeutics committee. 05/23/2017 Final File Amendment 119.03 06/02/2017 N
Pharmacy and therapeutics committee. 03/16/2017 Original File Amendment 119.03 04/25/2017 N
Pharmacy and therapeutics committee. 09/19/2016 Final File Amendment 119.03 10/01/2016 N
Pharmacy and therapeutics committee. 07/13/2016 Original File Amendment 119.03 08/18/2016 N
Pharmacy and therapeutics committee. 08/26/2015 No Change No Change 119.03 Y
Pharmacy and therapeutics committee. 01/10/2012 Final File Amendment 119.03 02/01/2012 N
Pharmacy and therapeutics committee. 11/01/2011 Original File Amendment 119.03 12/09/2011 N
Pharmacy and Therapeutics Committee . 12/30/2010 Final File New 119.03 01/10/2011 N
Pharmacy and Therapeutics Committee . 10/25/2010 Original File New 119.03 11/30/2010 N